A detailed history of Clari Vest Asset Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 575,251 shares of ADMA stock, worth $11.2 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
575,251
Previous 569,225 1.06%
Holding current value
$11.2 Million
Previous $3.76 Million 71.22%
% of portfolio
0.67%
Previous 0.4%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$5.98 - $11.18 $36,035 - $67,370
6,026 Added 1.06%
575,251 $6.43 Million
Q1 2024

May 06, 2024

BUY
$4.4 - $6.74 $1.63 Million - $2.5 Million
370,319 Added 186.18%
569,225 $3.76 Million
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $14,562 - $21,370
4,728 Added 2.43%
198,906 $899,000
Q3 2023

Nov 13, 2023

SELL
$3.47 - $4.61 $888 - $1,180
-256 Reduced 0.13%
194,178 $695,000
Q2 2023

Aug 14, 2023

BUY
$3.12 - $4.22 $606,634 - $820,511
194,434 New
194,434 $717,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.81B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.